Geode Capital Management, LLC Vyne Therapeutics Inc. Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
SELL
$0.12 - $4.91 $134 - $5,489
-1,118 Reduced 0.25%
449,085 $67,000
Q2 2022

Aug 12, 2022
SELL
$0.37 - $0.71 $7,488 - $14,368
-20,238 Reduced 4.3%
450,203 $175,000
Q3 2021

Nov 12, 2021
BUY
$1.39 - $3.47 $5,340 - $13,331
3,842 Added 0.82%
470,441 $653,000
Q2 2021

Aug 13, 2021
SELL
$3.24 - $6.92 $852,197 - $1.82 Million
-263,024 Reduced 36.05%
466,599 $1.64 Million
Q1 2021

May 12, 2021
BUY
$6.34 - $12.68 $4.63 Million - $9.25 Million
729,623 New
729,623 $4.99 Million

Others Institutions Holding VYNE

# of Institutions
2
Shares Held
36.5K
Call Options Held
0
Put Options Held
0
View Full List

About VYNE Therapeutics Inc.

VYNE Quotes by TradingView
  • Ticker VYNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,005,600
  • Market Cap $184M
  • Description
  • VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...
More about VYNE
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email